$LUCD
Lucid Diagnostics Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224044799 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.200M
YoY Change 53.26%
Cost Of Revenue $1.684M
YoY Change 3.31%
Gross Profit -$512.0K
YoY Change -39.76%
Gross Profit Margin -42.67%
Selling, General & Admin $9.411M
YoY Change 15.37%
% of Gross Profit
Research & Development $1.666M
YoY Change 3.16%
% of Gross Profit
Depreciation & Amortization $215.0K
YoY Change -65.32%
% of Gross Profit
Operating Expenses $12.87M
YoY Change 8.02%
Operating Profit -$11.69M
YoY Change 5.09%
Interest Expense $1.000K
YoY Change -99.33%
% of Operating Profit
Other Income/Expense, Net -$677.0K
YoY Change -78.02%
Pretax Income -$12.37M
YoY Change -12.93%
Income Tax
% Of Pretax Income
Net Earnings -$12.37M
YoY Change -12.93%
Net Earnings / Revenue -1030.92%
Basic Earnings Per Share -$0.25
Diluted Earnings Per Share -$0.25
COMMON SHARES
Basic Shares Outstanding 59.34M shares 53.99M shares
Diluted Shares Outstanding 50.37M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.49M
YoY Change -39.75%
Cash & Equivalents $14.49M
Short-Term Investments
Other Short-Term Assets $1.645M
YoY Change -49.23%
Inventory $651.0K
Prepaid Expenses
Receivables $39.00K
Other Receivables $0.00
Total Short-Term Assets $16.82M
YoY Change -38.38%
LONG-TERM ASSETS
Property, Plant & Equipment $940.0K
YoY Change -26.79%
Goodwill
YoY Change
Intangibles $842.0K
YoY Change -56.35%
Long-Term Investments
YoY Change
Other Assets $1.132M
YoY Change -0.18%
Total Long-Term Assets $5.774M
YoY Change -2.81%
TOTAL ASSETS
Total Short-Term Assets $16.82M
Total Long-Term Assets $5.774M
Total Assets $22.60M
YoY Change -32.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.135M
YoY Change 14.19%
Accrued Expenses $2.861M
YoY Change -35.71%
Deferred Revenue
YoY Change
Short-Term Debt $10.25M
YoY Change -58.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.25M
YoY Change -52.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $2.011M
YoY Change 337.17%
Total Long-Term Liabilities $2.011M
YoY Change 337.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.25M
Total Long-Term Liabilities $2.011M
Total Liabilities $16.26M
YoY Change -47.02%
SHAREHOLDERS EQUITY
Retained Earnings -$192.2M
YoY Change 37.39%
Common Stock $52.00K
YoY Change 23.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.338M
YoY Change
Total Liabilities & Shareholders Equity $22.60M
YoY Change -32.02%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$12.37M
YoY Change -12.93%
Depreciation, Depletion And Amortization $215.0K
YoY Change -65.32%
Cash From Operating Activities -$10.17M
YoY Change 15.89%
INVESTING ACTIVITIES
Capital Expenditures $350.0K
YoY Change 1650.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$350.0K
YoY Change 1650.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 94.00K
YoY Change -65.19%
NET CHANGE
Cash From Operating Activities -10.17M
Cash From Investing Activities -350.0K
Cash From Financing Activities 94.00K
Net Change In Cash -10.43M
YoY Change 22.29%
FREE CASH FLOW
Cash From Operating Activities -$10.17M
Capital Expenditures $350.0K
Free Cash Flow -$10.52M
YoY Change 19.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40901
dei Entity Registrant Name
EntityRegistrantName
LUCID DIAGNOSTICS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-5488042
dei Entity Address Address Line1
EntityAddressAddressLine1
360 Madison Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
25th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
(917)
dei Local Phone Number
LocalPhoneNumber
813-1828
dei Trading Symbol
TradingSymbol
LUCD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q3 LUCD Loss On Issue And Offering Costs Senior Secured Convertible Note
LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote
usd
CY2023Q3 LUCD Loss On Issue And Offering Costs Senior Secured Convertible Note
LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote
usd
LUCD Loss On Issue And Offering Costs Senior Secured Convertible Note
LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55495158 shares
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59342479 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14489000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18896000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
651000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
278000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1645000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2854000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
16824000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
22073000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
940000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1334000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2860000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1307000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1424000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1132000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1132000 usd
CY2024Q3 us-gaap Assets
Assets
22598000 usd
CY2023Q4 us-gaap Assets
Assets
27270000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1135000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1146000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2006000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3841000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
855000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1106000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
10200000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
13950000 usd
CY2024Q3 LUCD Due To Parent Msa Fee And Operating Expenses
DueToParentMSAFeeAndOperatingExpenses
53000 usd
CY2023Q4 LUCD Due To Parent Msa Fee And Operating Expenses
DueToParentMSAFeeAndOperatingExpenses
9339000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14249000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29382000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2011000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
199000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
16260000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
29581000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
55919000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
18625000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51597718 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51597718 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42329864 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42329864 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
52000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
142592000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
129763000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-192225000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150741000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
6338000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2311000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22598000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27270000 usd
CY2024Q3 us-gaap Revenues
Revenues
1172000 usd
CY2023Q3 us-gaap Revenues
Revenues
783000 usd
us-gaap Revenues
Revenues
3149000 usd
us-gaap Revenues
Revenues
1388000 usd
CY2024Q3 LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
1684000 usd
CY2023Q3 LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
1634000 usd
LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
4954000 usd
LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
4522000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4056000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3837000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12459000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11996000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5355000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4320000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14292000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15049000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
105000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
505000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
582000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1516000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1666000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1615000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4539000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5334000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
11911000 usd
us-gaap Operating Expenses
OperatingExpenses
36826000 usd
us-gaap Operating Expenses
OperatingExpenses
38417000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11694000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11128000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-37029000 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
81000 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
116000 usd
us-gaap Interest Income Other
InterestIncomeOther
256000 usd
us-gaap Interest Income Other
InterestIncomeOther
330000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
1000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
149000 usd
us-gaap Interest Expense
InterestExpense
19000 usd
us-gaap Interest Expense
InterestExpense
405000 usd
CY2024Q3 LUCD Change In Fair Value Senior Secured Convertible Note
ChangeInFairValueSeniorSecuredConvertibleNote
322000 usd
CY2023Q3 LUCD Change In Fair Value Senior Secured Convertible Note
ChangeInFairValueSeniorSecuredConvertibleNote
3021000 usd
LUCD Change In Fair Value Senior Secured Convertible Note
ChangeInFairValueSeniorSecuredConvertibleNote
-568000 usd
LUCD Change In Fair Value Senior Secured Convertible Note
ChangeInFairValueSeniorSecuredConvertibleNote
3520000 usd
LUCD Loss On Issue And Offering Costs Senior Secured Convertible Note
LossOnIssueAndOfferingCostsSeniorSecuredConvertibleNote
1186000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1116000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-677000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3080000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-311000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4807000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12371000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14208000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33988000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41836000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-12371000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-14208000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33988000 usd
us-gaap Net Income Loss
NetIncomeLoss
-41836000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7496000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12371000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14208000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41484000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41836000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50374146 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50374146 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41862805 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41862805 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47876015 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47876015 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41558979 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41558979 shares
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1185000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
43000 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001799011
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2023Q3 LUCD Stock Issued During Period Value Asset Acquisitions Installment Payments
StockIssuedDuringPeriodValueAssetAcquisitionsInstallmentPayments
usd
CY2023Q3 LUCD Stock Issued During Period Value Issuance Committed Equity Facility Net Of Deferred Financing Charges
StockIssuedDuringPeriodValueIssuanceCommittedEquityFacilityNetOfDeferredFinancingCharges
usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
LUCD Loss On Issue Senior Secured Convertible Note
LossOnIssueSeniorSecuredConvertibleNote
usd
LUCD Issue Common Stock Settle Termination Payment
IssueCommonStockSettleTerminationPayment
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
LUCD Proceeds Issuance Of Common Stock At The Market Facility
ProceedsIssuanceOfCommonStockAtTheMarketFacility
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2024Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
CY2023Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
usd
dei Document Type
DocumentType
10-Q
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
842000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
12866000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-33677000 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-435000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-26000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-26000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
15979000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1758000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
94000 usd
CY2024Q3 LUCD Adjustments To Additional Paid In Capital Transfer Of Intellectual Property From Pavmed Inc
AdjustmentsToAdditionalPaidInCapitalTransferOfIntellectualPropertyFromPavmedInc
-350000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-12371000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
6338000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2311000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3034000 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
329000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4299000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
447000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5670000 usd
LUCD Stock Issued During Period Value New Exchange Series And Series A1 Preferred Stock
StockIssuedDuringPeriodValueNewExchangeSeriesAndSeriesA1PreferredStock
-31791000 usd
LUCD Stock Issued During Period Value New Issuance Through Exchange Series B And Series B1 Preferred Stock
StockIssuedDuringPeriodValueNewIssuanceThroughExchangeSeriesBAndSeriesB1PreferredStock
31790000 usd
LUCD Stock Issued During Period Shares New Issuance Through Sale Series B And Series B1 Preferred Stock
StockIssuedDuringPeriodSharesNewIssuanceThroughSaleSeriesBAndSeriesB1PreferredStock
24129000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4675000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
401000 usd
LUCD Adjustments To Additional Paid In Capital Transfer Of Intellectual Property From Pavmed Inc
AdjustmentsToAdditionalPaidInCapitalTransferOfIntellectualPropertyFromPavmedInc
-350000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
6338000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
15071000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1032000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
220000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
166000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
275000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-14208000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2556000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23047000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23047000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5014000 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
845000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
166000 usd
LUCD Stock Issued During Period Value Asset Acquisitions Termination Payment
StockIssuedDuringPeriodValueAssetAcquisitionsTerminationPayment
713000 usd
LUCD Stock Issued During Period Value At The Market Facility Net Of Deferred Financing Charges
StockIssuedDuringPeriodValueAtTheMarketFacilityNetOfDeferredFinancingCharges
284000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
551000 usd
LUCD Stock Issued During Period Value New Issuance Series A Preferred Stock
StockIssuedDuringPeriodValueNewIssuanceSeriesAPreferredStock
13625000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
147000 usd
us-gaap Net Income Loss
NetIncomeLoss
-41836000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2556000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2556000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33988000 usd
us-gaap Net Income Loss
NetIncomeLoss
-41836000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
945000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1870000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3034000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5014000 usd
LUCD Share Based Compensation Of Parent
ShareBasedCompensationOfParent
329000 usd
LUCD Share Based Compensation Of Parent
ShareBasedCompensationOfParent
845000 usd
LUCD Change In Fair Value Senior Secured Convertible Note
ChangeInFairValueSeniorSecuredConvertibleNote
-568000 usd
LUCD Change In Fair Value Senior Secured Convertible Note
ChangeInFairValueSeniorSecuredConvertibleNote
3520000 usd
LUCD Loss On Issue Senior Secured Convertible Note
LossOnIssueSeniorSecuredConvertibleNote
1111000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1116000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-26000 usd
LUCD Issue Common Stock Settle Termination Payment
IssueCommonStockSettleTerminationPayment
713000 usd
LUCD Operating Expenses Settled With Amortization Of Common Stock
OperatingExpensesSettledWithAmortizationOfCommonStock
248000 usd
LUCD Operating Expenses Settled With Amortization Of Common Stock
OperatingExpensesSettledWithAmortizationOfCommonStock
23000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1065000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1262000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-62000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1836000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1878000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-4611000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5326000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34269000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22838000 usd
LUCD Payments Of Purchase Of Equipment
PaymentsOfPurchaseOfEquipment
37000 usd
LUCD Payments Of Purchase Of Equipment
PaymentsOfPurchaseOfEquipment
46000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
350000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-387000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
29798000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
13625000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
10000000 usd
LUCD Proceeds Issuance Of Common Stock At The Market Facility
ProceedsIssuanceOfCommonStockAtTheMarketFacility
284000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000 usd
LUCD Proceeds From Issuance Of Common Stock One
ProceedsFromIssuanceOfCommonStockOne
447000 usd
LUCD Proceeds From Issuance Of Common Stock One
ProceedsFromIssuanceOfCommonStockOne
551000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30249000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24460000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4407000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1576000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18896000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22474000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14489000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24050000 usd
CY2024Q3 us-gaap Revenues
Revenues
1200000 usd
us-gaap Revenues
Revenues
3100000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41500000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34300000 usd
CY2024Q3 LUCD Working Capital
WorkingCapital
2600000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
10200000 usd
CY2024Q3 us-gaap Cash
Cash
14500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zpSFwFWb4LX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zCneKyuEGNdh">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the unaudited condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and the determination of corresponding carrying value reserves, if any, and liabilities and the disclosure of contingent losses, as of the date of the unaudited condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Significant estimates in these unaudited condensed consolidated financial statements include those related to the estimated fair value of debt obligations, stock-based equity awards and intangible assets. Other significant estimates include the estimated incremental borrowing rate, the provision or benefit for income taxes and the corresponding valuation allowance on deferred tax assets. Additionally, management’s assessment of the Company’s ability to continue as a going concern involves the estimation of the amount and timing of future cash inflows and outflows. On an ongoing basis, the Company evaluates its estimates and assumptions. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1172000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3149000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
783000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1388000 usd
CY2024Q3 LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
1684000 usd
LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
4954000 usd
CY2023Q3 LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
1634000 usd
LUCD Operating Cost Of Revenue
OperatingCostOfRevenue
4522000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9339000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
8150000 usd
LUCD Employee Retention Credit Benefits
EmployeeRetentionCreditBenefits
1411000 usd
LUCD On Behalf Of Obo Activities
OnBehalfOfOBOActivities
598000 usd
LUCD Cash Payments
CashPayments
-14770000 usd
LUCD Payment To Related Parties
PaymentToRelatedParties
-4675000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
53000 usd
CY2024Q3 LUCD Assignment Fee
AssignmentFee
350000 usd
CY2024Q3 LUCD Prepaid Service Providers And Suppliers
PrepaidServiceProvidersAndSuppliers
389000 usd
CY2023Q4 LUCD Prepaid Service Providers And Suppliers
PrepaidServiceProvidersAndSuppliers
266000 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
49000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
607000 usd
CY2024Q3 us-gaap Security Deposit
SecurityDeposit
1207000 usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
1981000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1645000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2854000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
2600000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
266000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1025000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
979000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
940000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
19000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3229000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
363000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2866000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
889000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
894000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2347000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
380000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M1D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07875 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07875 pure
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2860000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1307000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2866000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1305000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
855000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1106000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2011000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
199000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5305000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5305000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4463000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3881000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
842000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1424000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
105000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
505000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
582000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1516000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
105000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
421000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
316000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
842000 usd
CY2024Q3 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
10200000 usd
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
13950000 usd
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
8669000 usd
CY2024Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
10200000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
11019000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
13950000 usd
CY2023Q1 us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.825 pure
CY2023Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.30
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5504383 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.00
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
765000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3604000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.22
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3333 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.31
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
442501 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.63
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8662549 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.69
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
197000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3654937 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.19
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y2M12D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
197000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1228000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1252000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3363000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5859000 usd
CY2024Q1 LUCD Fair Value Of Series B Preferred Stock Issued Shares
FairValueOfSeriesBPreferredStockIssuedShares
31790 shares
CY2024Q1 LUCD Fair Value Of Series B Preferred Stock Issued
FairValueOfSeriesBPreferredStockIssued
31790000 usd
CY2024Q1 LUCD Carrying Value Related To Series And Series A1 Preferred Stock Exchanged For Series B Preferred Stock Shares
CarryingValueRelatedToSeriesAndSeriesA1PreferredStockExchangedForSeriesBPreferredStockShares
24295 shares
CY2024Q1 LUCD Carrying Value Related To Series And Series A1 Preferred Stock Exchanged For Series B Preferred Stock
CarryingValueRelatedToSeriesAndSeriesA1PreferredStockExchangedForSeriesBPreferredStock
24294000 usd
CY2024Q1 LUCD Deemed Dividend Charged To Accumulated Deficit
DeemedDividendChargedToAccumulatedDeficit
7496000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51597718 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51597718 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42329864 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42329864 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
480000 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
401000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-12371000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-14208000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33988000 usd
us-gaap Net Income Loss
NetIncomeLoss
-41836000 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7496000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12371000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14208000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41484000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41836000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50374146 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50374146 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41862805 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41862805 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47876015 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47876015 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41558979 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41558979 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.01
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
64242367 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20428302 shares
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-044799-index-headers.html Edgar Link pending
0001493152-24-044799-index.html Edgar Link pending
0001493152-24-044799.txt Edgar Link pending
0001493152-24-044799-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
lucd-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lucd-20240930_cal.xml Edgar Link unprocessable
lucd-20240930_def.xml Edgar Link unprocessable
lucd-20240930_lab.xml Edgar Link unprocessable
lucd-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending